Fortún J, Gómez-Mampaso E, Navas E, Hermida J M, Antela A, Guerrero A
Sección de Enfermedades Infecciosas, Hospital Ramón y Cajal, Madrid.
Enferm Infecc Microbiol Clin. 1994 Mar;12(3):150-3.
Tuberculosis in HIV infected patients does not carry a worse therapeutic response rate. Treatment failure is usually due to incomplete schedule, with development of acquired resistance. Two patients with HIV infection and disseminated tuberculosis who developed fatal meningitis are presented.
In vitro studies of sensitivity to anti-tuberculous drugs were carried out, using the proportions method.
Following a good initial evolution, both patients were readmitted with tuberculous meningitis resistant to isoniazide in both and to rifampicin in one of the patients. In one patient, the original strain (which was sensitive) was available. In this patient, changes in the treatment were performed in the initial phase.
The importance of anti-tuberculous multiple therapy, particularly in the initial phases, for HIV positive patients is crucial. The lengthen of admission when good patient's compliance is in question, but also to avoid, whenever possible, changes in treatment are important measures in this stage. Meningitis may occur as a form of therapeutic failure and its cure may be difficult if the strains are resistant.
HIV感染患者的结核病治疗反应率并不更差。治疗失败通常是由于治疗方案不完整以及获得性耐药的出现。本文介绍了两名患有HIV感染和播散性结核病并发展为致命性脑膜炎的患者。
采用比例法对抗结核药物进行体外敏感性研究。
在最初病情良好进展后,两名患者均因结核性脑膜炎再次入院,两人对异烟肼均耐药,其中一人对利福平耐药。在一名患者中,可以获得原始菌株(该菌株敏感)。在该患者中,可以在初始阶段对治疗方案进行调整。
对于HIV阳性患者,特别是在初始阶段,联合抗结核治疗至关重要。当患者依从性存疑时延长住院时间,以及尽可能避免治疗方案的改变,是这一阶段的重要措施。脑膜炎可能作为治疗失败的一种形式出现,如果菌株耐药,其治愈可能会很困难。